Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ubiquinol in post-cardiac arrest
NCT02934555Phase 2Completed
- Sponsor
- Beth Israel Deaconess Medical Center
- Start
- Mar 2016
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of coenzyme q10 in cardiac arrest (SCA) (2 arms), sponsored by Beth Israel Deaconess Medical Center. Primary endpoint: Coenzyme Q10 Plasma Levels at 72 hours. Started Mar 2016; status: completed.
02
Drugs
coenzyme q10
03
Conditions
cardiac arrest (SCA)
Beyond the preview
Go deeper on NCT02934555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02934555.